You may be able to keep some or all of the weight off if you add weight management strategies to your semaglutide treatment, particularly if you keep them up after stopping the drug
Metabolic syndrome is a cluster of conditions-increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels-that occur together, increasing your risk of heart disease, stroke, and type 2 diabetes
Some cover all approved medications while others specifically exclude weight loss drugs
This side effect was more noticeable in patients who received the GLP-1RA treatment off-label, as a weight-loss medication
Building these habits during the active weight loss phase, rather than relying solely on medication-induced appetite suppression, increases the likelihood of successful long-term maintenance whether or not medication continues
Tests in obese mice indicated the triple agonist was more powerful than dual agonists in correcting obesity and diabetes (Finan, Yang, Ottaway)
